Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

ICON plc - Ordinary Shares (NQ:ICLR)

186.35 -0.30 (-0.16%)
Streaming Delayed Price Updated: 12:54 PM EDT, Oct 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ICON plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
What Analysts Are Saying About Icon Stock
 
Via Benzinga
ICON PLC (NASDAQ:ICLR): A Value Investing Case Study
ICON PLC (ICLR) presents a strong value investing case with attractive P/E ratios, solid profitability, and stable financial health, suggesting potential undervaluation. 
Via Chartmill
ICON plc Schedules Third Quarter 2025 Earnings Conference Call
From ICON plc
Via Business Wire
11 Analysts Assess Icon: What You Need To Know
 
Via Benzinga
ICON Announces CEO Transition
From ICON plc
Via Business Wire
Earnings Scheduled For July 23, 2025
 
Via Benzinga
Insights Ahead: Icon's Quarterly Earnings
 
Via Benzinga
ICON plc to Participate at Upcoming Investor Conferences
From ICON plc
Via Business Wire
3 Healthcare Pathbreakers With Long-Term Tailwinds
These three firms in the fast-changing healthcare sector stand out to analysts for their strong product lineups, defensible technology, and notable pipelines. 
Via MarketBeat
Assessing Icon: Insights From 8 Financial Analysts
 
Via Benzinga
ICON PLC (NASDAQ:ICLR) Presents a Compelling Value Investment Opportunity with Strong Fundamentals
ICON PLC (ICLR) is a value stock with strong valuation metrics, solid profitability, and stable financials, trading below industry averages. A potential undervalued opportunity for investors. 
Via Chartmill
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio?
Medpace, ICON, and West Pharma led last week's large-cap rally, driven by strong earnings beats and upgraded guidance. 
Via Benzinga
Topics Earnings
ICON Stock Up After Q2 Results Signal Growing Confidence In Biopharma Recovery
ICON lifts its 2025 revenue forecast, beats booking targets in Q2 and expands its share buyback plan as market conditions remain variable. 
Via Benzinga
RPM International Posts Better-Than-Expected Earnings, Joins ICON, MaxLinear, Nasdaq And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
Thursday's session: gap up and gap down stocks
Today's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
This Spotify Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
 
Via Benzinga
Why Alphabet Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
ICON PLC (NASDAQ:ICLR) Reports Q2 2025 Earnings Slightly Below Estimates, Shares Surge 13.76% in After-Hours Trading
ICON PLC (ICLR) reported Q2 2025 earnings slightly below estimates but saw a 13.76% stock surge. Revenue hit $2.02B, EPS $3.26. AGM resolutions passed, boosting investor confidence. 
Via Chartmill
Wednesday's after hours session: top gainers and losers
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
ICON Announces Results of Annual General Meeting
From ICON plc
Via Business Wire
ICON Reports Second Quarter 2025 Results
From ICON plc
Via Business Wire
D.R. Horton, IQVIA Holdings, Northrop Grumman And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report
From ICON plc
Via Business Wire
ICON PLC (NASDAQ:ICLR) – A Potentially Undervalued Stock in the Life Sciences Sector
ICON PLC (NASDAQ:ICLR) appears undervalued with strong profitability and reasonable financial health, making it a potential candidate for value investors in the life sciences sector. 
Via Chartmill
LVM Capital Management Dumps 16,000 ICON Public Shares Worth $2.6 million
Via The Motley Fool
Topics Regulatory Compliance
ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability
From ICON plc
Via Business Wire
ICON plc Schedules Second Quarter 2025 Earnings Conference Call
From ICON plc
Via Business Wire
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
ICON plc to Present at the William Blair 45th Annual Growth Stock Conference
From ICON plc
Via Business Wire
ICON releases its ICON Cares 2024 Report
From ICON plc
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.